These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 19405154)

  • 1. Gene-expression-based quality scores indicate optimal harvest point in Bordetella pertussis cultivation for vaccine production.
    van de Waterbeemd B; Streefland M; Pennings J; van der Pol L; Beuvery C; Tramper J; Martens D
    Biotechnol Bioeng; 2009 Aug; 103(5):900-8. PubMed ID: 19405154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of a critical process parameter: oxygen limitation during cultivation has a fully reversible effect on gene expression of Bordetella pertussis.
    Streefland M; van de Waterbeemd B; Kint J; van der Pol LA; Beuvery EC; Tramper J; Martens DE
    Biotechnol Bioeng; 2009 Jan; 102(1):161-7. PubMed ID: 18683249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PAT for vaccines: the first stage of PAT implementation for development of a well-defined whole-cell vaccine against whooping cough disease.
    Streefland M; van de Waterbeemd B; Happé H; van der Pol LA; Beuvery EC; Tramper J; Martens DE
    Vaccine; 2007 Apr; 25(16):2994-3000. PubMed ID: 17313999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of relevant culture parameters on Pertussis Toxin expression by Bordetella pertussis.
    Thalen M; Venema M; van den IJssel J; Berwald L; Beuvery C; Martens D; Tramper J
    Biologicals; 2006 Sep; 34(3):213-20. PubMed ID: 16497513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteome Analysis Is a Valuable Tool to Monitor Antigen Expression during Upstream Processing of Whole-Cell Pertussis Vaccines.
    Metz B; Hoonakker M; Uittenbogaard JP; Weyts M; Mommen GP; Meiring HD; Tilstra W; Pennings JL; van der Pol LA; Kuipers B; Sloots A; van den IJssel J; van de Waterbeemd B; van der Ark A
    J Proteome Res; 2017 Feb; 16(2):528-537. PubMed ID: 27977922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Constant specific growth rate in fed-batch cultivation of Bordetella pertussis using adaptive control.
    Soons ZI; Voogt JA; van Straten G; van Boxtel AJ
    J Biotechnol; 2006 Sep; 125(2):252-68. PubMed ID: 16621094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comparison between two types of pertussis vaccines].
    Bisaillon JG
    Rev Can Biol; 1977 Sep; 36(3):283-9. PubMed ID: 200987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improving the cellular pertussis vaccine: increased potency and consistency.
    Thalen M; van der Ark A; van den Ijssel J; van Straaten I; Jansen D; Beuvery C; Martens D; Tramper J
    Vaccine; 2008 Jan; 26(5):653-63. PubMed ID: 18155325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fed-batch cultivation of Bordetella pertussis: metabolism and Pertussis Toxin production.
    Thalen M; Venema M; Dekker A; Berwald L; van den IJssel J; Zomer B; Beuvery C; Martens D; Tramper J
    Biologicals; 2006 Dec; 34(4):289-97. PubMed ID: 16500113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A practical approach for exploration and modeling of the design space of a bacterial vaccine cultivation process.
    Streefland M; Van Herpen PF; Van de Waterbeemd B; Van der Pol LA; Beuvery EC; Tramper J; Martens DE; Toft M
    Biotechnol Bioeng; 2009 Oct; 104(3):492-504. PubMed ID: 19598176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies on culture conditions of Bordetella pertussis and relationship to immunogenicity of vaccines.
    Bellalou J; Relyveld EH
    Ann Microbiol (Paris); 1984; 135B(1):101-10. PubMed ID: 6095715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The expression of Bordetella pertussis protective antigens during bacterial multiplication on a medium with a fixed chemical composition].
    Shmeleva EI; Mertsalova NU; Sukhinova EV; Kirillova GA; Remova TN; Bazhanova IG; Ozeretskovskaia MN; Britsina MV; Ermolova EV; Zakharova NS
    Zh Mikrobiol Epidemiol Immunobiol; 1997; (2):47-50. PubMed ID: 9245141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation between optical density and viable germ count during cultivation of B. pertussis.
    Csizér Z; Pusztai Z; Joó I
    Zentralbl Bakteriol Orig; 1971; 216(2):215-8. PubMed ID: 4325114
    [No Abstract]   [Full Text] [Related]  

  • 14. The Bordetella type III secretion system: its application to vaccine development.
    Abe A; Nagamatsu K; Watanabe M
    Microbiol Immunol; 2008 Feb; 52(2):128-33. PubMed ID: 18380810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bordetella pertussis strain variation and evolution postvaccination.
    Kallonen T; He Q
    Expert Rev Vaccines; 2009 Jul; 8(7):863-75. PubMed ID: 19538113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid and accurate typing of Bordetella pertussis targeting genes encoding acellular vaccine antigens using real time PCR and High Resolution Melt analysis.
    Chan WF; Maharjan RP; Reeves PR; Sintchenko V; Gilbert GL; Lan R
    J Microbiol Methods; 2009 Jun; 77(3):326-9. PubMed ID: 19341769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Antigenic activity of Bordetella pertussis during cultivation in liquid nutrient media].
    Miriasova LV; Moshiashvili IIa; Basnak'ian IA; Sergeev VV; Zaporozhtsev LN
    Zh Mikrobiol Epidemiol Immunobiol; 1978 Jun; (6):31-6. PubMed ID: 209647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth phase- and nutrient limitation-associated transcript abundance regulation in Bordetella pertussis.
    Nakamura MM; Liew SY; Cummings CA; Brinig MM; Dieterich C; Relman DA
    Infect Immun; 2006 Oct; 74(10):5537-48. PubMed ID: 16988229
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pertussis vaccine--fact and fiction.
    Cameron J; Stainer DW
    Acta Microbiol Acad Sci Hung; 1977; 24(3):195-205. PubMed ID: 203169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Development of a fermentation process in the production of pertussis vaccine].
    Recamier L; Medina A; Rodríguez H
    Salud Publica Mex; 1981; 23(6):563-73. PubMed ID: 6278655
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.